APPROVAL OF THE NOVAVAX COVID 19 VACCINE
Effective October 3, 2023, the Federal Drug Administration (FDA) announced the approval of the updated 2023–2024 monovalent XBB.1.5 variant Novavax COVID-19 Vaccine, Adjuvanted.
last updated: March 13, 2024
Effective October 3, 2023, the Federal Drug Administration (FDA) announced the approval of the updated 2023–2024 monovalent XBB.1.5 variant Novavax COVID-19 Vaccine, Adjuvanted.
MetroPlusHealth members can access the Member Portal, find doctors, specialists, and pharmacies, and view member benefits.
Join the MetroPlusHealth Member Advisory Board (MAB)